Hamid Hasson

1.7k total citations
69 papers, 792 citations indexed

About

Hamid Hasson is a scholar working on Infectious Diseases, Virology and Hepatology. According to data from OpenAlex, Hamid Hasson has authored 69 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Infectious Diseases, 30 papers in Virology and 30 papers in Hepatology. Recurrent topics in Hamid Hasson's work include HIV/AIDS drug development and treatment (33 papers), HIV Research and Treatment (30 papers) and Hepatitis C virus research (28 papers). Hamid Hasson is often cited by papers focused on HIV/AIDS drug development and treatment (33 papers), HIV Research and Treatment (30 papers) and Hepatitis C virus research (28 papers). Hamid Hasson collaborates with scholars based in Italy, United States and Japan. Hamid Hasson's co-authors include Adriano Lazzarin, Antonella Castagna, Laura Galli, Anna Danise, Nicola Gianotti, Massimo Clementi, Enzo Boeri, Stefano Menzo, Elisabetta Carini and Caterina Uberti‐Foppa and has published in prestigious journals such as Blood, PLoS ONE and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Hamid Hasson

64 papers receiving 767 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hamid Hasson Italy 13 468 345 224 171 142 69 792
Paola Cicconi Italy 17 489 1.0× 369 1.1× 351 1.6× 130 0.8× 301 2.1× 45 881
María Stella Mura Italy 16 394 0.8× 169 0.5× 349 1.6× 230 1.3× 148 1.0× 31 826
George Perez United States 15 413 0.9× 169 0.5× 353 1.6× 70 0.4× 143 1.0× 36 785
Corklin Steinhart United States 10 391 0.8× 275 0.8× 141 0.6× 74 0.4× 169 1.2× 21 566
Ronald D’Amico United States 19 528 1.1× 364 1.1× 238 1.1× 37 0.2× 139 1.0× 70 942
Britt Stancil United States 9 455 1.0× 329 1.0× 207 0.9× 75 0.4× 67 0.5× 12 850
Peter Gute Germany 18 868 1.9× 688 2.0× 308 1.4× 65 0.4× 216 1.5× 35 1.2k
Srini Ramanathan United States 11 417 0.9× 210 0.6× 338 1.5× 54 0.3× 85 0.6× 34 833
Abiy Habtewold Ethiopia 15 361 0.8× 158 0.5× 172 0.8× 81 0.5× 45 0.3× 25 728
Stéphanie Dominguez France 16 590 1.3× 370 1.1× 553 2.5× 518 3.0× 141 1.0× 39 1.1k

Countries citing papers authored by Hamid Hasson

Since Specialization
Citations

This map shows the geographic impact of Hamid Hasson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamid Hasson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamid Hasson more than expected).

Fields of papers citing papers by Hamid Hasson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hamid Hasson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamid Hasson. The network helps show where Hamid Hasson may publish in the future.

Co-authorship network of co-authors of Hamid Hasson

This figure shows the co-authorship network connecting the top 25 collaborators of Hamid Hasson. A scholar is included among the top collaborators of Hamid Hasson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hamid Hasson. Hamid Hasson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morsica, Giulia, Gema Hernández, Davide Di Napoli, et al.. (2025). Prevalence of Hepatitis C Virus Among Hospitalized Patients in a Tertiary Hospital in Italy: The Basis for a National Screening Assessment Model?. Microorganisms. 13(1). 129–129.
2.
Iavarone, Massimo, Massimo Puoti, Hamid Hasson, et al.. (2025). Comparable 5‐Year Survival in People With and Without HIV Following Hepatocellular Carcinoma Diagnosis: A Multicenter Study. Liver International. 45(12). e70437–e70437.
3.
Morsica, Giulia, Laura Galli, Emanuela Messina, et al.. (2022). Levels of Alpha-Fetoprotein and Association with Mortality in Hepatocellular Carcinoma of HIV-1-Infected Patients. Journal of Oncology. 2022. 1–10. 5 indexed citations
4.
Morsica, Giulia, Laura Galli, Emanuela Messina, et al.. (2022). Risk of HIV viral rebound in HIV infected patients on direct acting antivirals (DAAs) treatment for HCV. PLoS ONE. 17(2). e0262917–e0262917. 2 indexed citations
5.
Hasson, Hamid, A Ando, Fabrice André, et al.. (2020). 2020 Index IEEE Transactions on Plasma Science Vol. 48. IEEE Transactions on Plasma Science. 48(12). 4397–4501. 2 indexed citations
6.
Bagaglio, Sabrina, Caterina Uberti‐Foppa, Caterina Sagnelli, et al.. (2020). HIV-1 recombinant forms in immigrants regularly residing in Milan, northern Italy. Infection. 48(4). 553–558. 7 indexed citations
7.
Gaeta, Giovanni Battista, Alessio Aghemo, Barbara Menzaghi, et al.. (2018). Effectiveness and safety of simeprevir-based regimens for hepatitis C in Italy. Medicine. 97(27). e11307–e11307. 2 indexed citations
8.
Sagnelli, Caterina, Caterina Uberti‐Foppa, Hamid Hasson, et al.. (2017). Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients. PLoS ONE. 12(7). e0181890–e0181890. 11 indexed citations
9.
Sagnelli, Caterina, Marco Merli, Caterina Uberti‐Foppa, et al.. (2016). Impact of PNPLA3 variants on liver histology of 168 patients with HIV infection and chronic hepatitis C. Clinical Microbiology and Infection. 22(4). 372–378. 13 indexed citations
10.
Cossarini, Francesca, Laura Galli, Caterina Sagnelli, et al.. (2009). Survival of HIV-1 Infected Multidrug-Resistant Patients Recycling Enfuvirtide After a Previous Failure. JAIDS Journal of Acquired Immune Deficiency Syndromes. 51(2). 179–184. 4 indexed citations
11.
Hasson, Hamid, Barbara Mantelli, Priscilla Biswas, et al.. (2007). Favorable outcome of ex‐vivo purging of monocytes after the reintroduction of treatment after interruption in patients infected with multidrug resistant HIV‐1. Journal of Medical Virology. 79(11). 1640–1649. 5 indexed citations
12.
Burastero, Samuele E., Clara Paolucci, Daniela Breda, et al.. (2006). Immunological Basis for IgE Hyper-Production in Enfuvirtide-Treated HIV- Positive Patients. Journal of Clinical Immunology. 26(2). 168–176. 3 indexed citations
13.
Seminari, Elena, Laura Galli, Hamid Hasson, et al.. (2005). Higher plasma lopinavir concentrations are associated with a moderate rise in cholestasis markers in HIV-infected patients. Journal of Antimicrobial Chemotherapy. 56(4). 790–792. 13 indexed citations
14.
Hasson, Hamid, et al.. (2004). The introduction of the fusion inhibitors in the HAART-regimens.. Università Politecnica delle Marche (Università Politecnica delle Marche). 3 indexed citations
15.
Menzo, Stefano, Antonella Castagna, Alessia Monachetti, et al.. (2004). Resistance and replicative capacity of HIV-1 strains selected in vivo by long-term enfuvirtide treatment.. PubMed. 27(2 Suppl 1). 51–61. 16 indexed citations
16.
Hasson, Hamid, Nicola Gianotti, Anna Danise, et al.. (2004). Resistance to amprenavir before and after treatment with lopinavir/ritonavir in highly protease inhibitor-experienced HIV patients. AIDS. 18(1). 121–123. 5 indexed citations
17.
Boeri, Enzo, Nicola Gianotti, Filippo Canducci, et al.. (2003). Evolutionary Characteristics of HIV Type 1 Variants Resistant to Protease Inhibitors in the Absence of Drug-Selective Pressure. AIDS Research and Human Retroviruses. 19(12). 1151–1153. 16 indexed citations
18.
Gianotti, Nicola, Alessandro Soria, Laura Galli, et al.. (2003). Predictors of sustained response to therapy resumption after treatment interruption in HIV‐infected patients failing antiretroviral therapy. Journal of Medical Virology. 72(2). 181–186. 7 indexed citations
19.
Biswas, Priscilla, Barbara Mantelli, Hamid Hasson, et al.. (2003). In vivo modulation of leukocyte trafficking receptor following therapeutic purging of myeloid cells: implications for treatment of HIV infection and other immune disorders. Clinical Immunology. 109(3). 355–358. 11 indexed citations
20.
Brambilla, Anna Maria, Antonella Castagna, Hamid Hasson, et al.. (2001). Relation Between CD4 Cell Counts and HIV RNA Levels at Onset of Opportunistic Infections. JAIDS Journal of Acquired Immune Deficiency Syndromes. 27(1). 44–48. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paola Cicconi Breakdown of academic impact, for papers by María Stella Mura Breakdown of academic impact, for papers by George Perez Breakdown of academic impact, for papers by Corklin Steinhart Breakdown of academic impact, for papers by Ronald D’Amico Breakdown of academic impact, for papers by Britt Stancil Breakdown of academic impact, for papers by Peter Gute Breakdown of academic impact, for papers by Srini Ramanathan Breakdown of academic impact, for papers by Abiy Habtewold Breakdown of academic impact, for papers by Stéphanie Dominguez
Rankless by CCL
2026